نتایج جستجو برای: stents drug

تعداد نتایج: 598639  

Journal: :Interactive CardioVascular and Thoracic Surgery 2007

Journal: :BMJ : British Medical Journal 2008
Christoph Stettler Sabin Allemann Simon Wandel Adnan Kastrati Marie Claude Morice Albert Schömig Matthias E Pfisterer Gregg W Stone Martin B Leon José Suárez de Lezo Jean-Jacques Goy Seung-Jung Park Manel Sabaté Maarten J Suttorp Henning Kelbaek Christian Spaulding Maurizio Menichelli Paul Vermeersch Maurits T Dirksen Pavel Cervinka Marco De Carlo Andrejs Erglis Tania Chechi Paolo Ortolani Martin J Schalij Peter Diem Bernhard Meier Stephan Windecker Peter Jüni

OBJECTIVE To compare the effectiveness and safety of three types of stents (sirolimus eluting, paclitaxel eluting, and bare metal) in people with and without diabetes mellitus. DESIGN Collaborative network meta-analysis. DATA SOURCES Electronic databases (Medline, Embase, the Cochrane Central Register of Controlled Trials), relevant websites, reference lists, conference abstracts, reviews, ...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2016
Jarkko Hytönen Olli Leppänen Jan Hinrich Braesen Wolf-Hagen Schunck Dominik Mueller Friedrich Jung Christoph Mrowietz Martin Jastroch Michael von Bergwelt-Baildon Kai Kappert Arnd Heuser Jörg-Detlef Drenckhahn Burkert Pieske Ludwig Thierfelder Seppo Ylä-Herttuala Florian Blaschke

OBJECTIVE Drug-eluting coronary stents reduce restenosis rate and late lumen loss compared with bare-metal stents; however, drug-eluting coronary stents may delay vascular healing and increase late stent thrombosis. The peroxisome proliferator-activated receptor-delta (PPARδ) exhibits actions that could favorably influence outcomes after drug-eluting coronary stents placement. APPROACH AND RE...

Journal: :Postgraduate medical journal 2004
V Bhatia R Bhatia M Dhindsa

At present there is much excitement about drug-eluting stents, which hold promise for the treatment of coronary artery disease. This ingenious therapy involves coating the outside of a standard coronary stent with a thin polymer containing medication that can prevent scarring at the site of coronary intervention. Early trials with sirolimus coated stents showed that they might prevent coronary ...

2010
eVelyn reGar

The methodology in interventional cardiology has historically evolved from diagnostic coronary angiography to balloon angioplasty, to the use of bare metal stents (BmSs), to their refinement to drug-eluting stents with a durable polymer, and is now on the verge of drug-eluting stents with further developed drug delivery approaches such as reservoir technology and the use of bioresorbable polyme...

Journal: :Circulation 2004
Jürgen R Sindermann Gabriele Plenz Günter Breithardt

About Safety? To the Editor: Recently, Lemos et al1 and O’Neill and Leon2 provided a balanced overview about drug-eluting stents. The authors nicely addressed the various aspects of this new technology from the economical to the clinical side, including safety and side effects. We would like to supplement another important aspect of safety, the problem of drug interaction, which has not yet rec...

Journal: :Annals of Saudi medicine 2008
Walid Hassan

Ann Saudi Med 28(2) March-April 2008 www.kfshrc.edu.sa/annals 114 Drug-eluting stents have attracted considerable attention since their commercial approval more than 5 years ago when they were considered by some as one of the most important breakthroughs in the history of cardiovascular medicine. Different drug-eluting stents, with different drugs, different polymers, and different elution kine...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید